A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects

NCT02058407 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Drug related AEs observed upon repeat dosing that with longer treatment duration could become worse. Required action on some biomarkers not observed.

Conditions

Bronchiectasis

Interventions

DRUG: GSK2793660 solution
DRUG: GSK2793660 capsule
DRUG: Placebo solution
DRUG: Placebo capsule

Sponsor

GlaxoSmithKline